Intra-bone route of administration offers new perspectives for safer transplantation of hematopoietic stem cells.
Frassoni
Francesco
F
Stem Cell and Cell Therapy Centre, Ospedale San Martino, Genova, Italy. Francesco.Frassoni@hsanmartino.it
D000818:Animals; D001842:Bone and Bones / Q000166:cytology / Q000276:immunology / Q000601:surgery*; D049109:Cell Proliferation; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology; D006086:Graft vs Host Disease / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control*; D006402:Hematologic Diseases / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006801:Humans; D051379:Mice; D016513:Mice, SCID / Q000235:genetics / Q000276:immunology; D019172:Transplantation Conditioning / Q000009:adverse effects